drugset / Trial / NCT00765128

Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy

NCT00765128

Phase 4 Completed 17 enrolled Mayo Clinic
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having percutaneous nephrolithotomy for kidney stone disease.

Timeline

Start
2008-10
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketorolac Other / unclassified 90 mg Intravenous

Indications